Parallel Advisors »

Centessa Pharmaceuticals shares owned by Parallel Advisors

Quarter-by-quarter ownership of Centessa Pharmaceuticals shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $595 15 39.73

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Corcept Therapeutics Stock (CORT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Microsoft Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Amazon.com Stock (AMZN)
Avantis International Equity Etf Etf (AVDE)
Cvb Finl Corp Stock (CVBF)
Vanguard Large Cap Etf (VV)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Victoryshares Free Cash Flow Etf Etf (VFLO)

View all positions for Parallel Advisors

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
venBio Select Advisor
Adage Capital Partners GP
Pentwater Capital Management
FMR
EcoR1 Capital
Perceptive Advisors
Capital World Investors
Farallon Capital Management
TCG Crossover Management
Morgan Stanley
Paradigm Biocapital Advisors
Henderson Group
Deep Track Capital
Logos Global Management

View all funds holding Centessa Pharmaceuticals